Cagrilintide is a long-acting amylin analogue researched as a next-generation weight-management compound. It mimics amylin, a natural hormone that helps regulate appetite and energy balance, by acting on receptors in the brain to promote a feeling of fullness and reduce food intake. In clinical research it has produced significant weight loss on its own, with even greater results when paired with GLP-1 compounds like semaglutide.
Key information and effects
- Acts on receptors in the brain to promote satiety (feeling full) and reduce food intake.
- Clinical trials show it leads to significant weight loss (around 10-15% body weight) when used alone.
- Demonstrates even greater weight loss efficacy (potentially 15-20%+) when combined with GLP-1 receptor agonists like semaglutide.
- Offers a potential new treatment option for chronic weight management in individuals with obesity.
Disclaimer: This product is for laboratory research purposes only. Not for human or animal consumption. Cap colour subject to change.





Reviews
There are no reviews yet.